Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Clin Oncol. May 24, 2024; 15(5): 614-634
Published online May 24, 2024. doi: 10.5306/wjco.v15.i5.614
Table 3 Univariate and multifactorial logistic regression analysis of risk factors for regional lymph node metastases in patients with lung squamous cell carcinoma
Characteristic
Univariate analysis, OR (95%CI)
P value
Multivariate analysis, OR (95%CI)
P value
Age
    < 601-
    60-691.48 (0.71-3.07)0.291
    ≥ 700.75 (0.27-2.10)0.584
Tumor location
    Peripheral1-1-
    Central4.77 (2.36-9.63)0.0000a7.80 (3.33-18.26)0.0000a
Histology
    KSCC1-
    NKSCC0.77 (0.37-1.60)0.482
Tumor grade
    G11-
    G21.07 (0.50-2.29)0.858
    G30.78 (0.31-1.97)0.597
T stage
    T1a1-1-
    T1b5.50 (0.91-33.18)0.0634.93 (0.76-31.78)0.093
    T2a6.20 (1.42-27.09)0.015a2.82 (0.59-13.53)0.195
    T2b9.33 (1.45-60.21)0.019a5.27 (0.75-37.28)0.096
    T35.60 (1.24-25.25)0.026a1.66 (0.31-8.80)0.551
DCs with weak expression of CD34
    Absence1-
    Presence1.10 (0.56-2.15)0.783
DCs of "contact type"
    Presence1-
    Absence1.67 (0.86-3.25)0.13
The capillaries in the tumor solid component
    Absence1-1-
    Presence2.89 (1.33-6.28)0.008a2.72 (1.14-6.48)0.023a
LFFCT in the tumor stroma
    Absence1-
    Presence0.70 (0.32-1.55)0.383
Fragmentation in the tumor solid component
    Absence1-1-
    Presence2.55 (1.28-5.06)0.008a3.03 (1.33-6.94)0.009a
Retraction clefts
    Absence1-1-
    Presence2.62 (1.33-5.16)0.005a3.52 (1.56-7.96)0.003a
Tumor spread through the AAS
    Absence1-
    Presence0.72 (0.37-1.42)0.342